Cvs Health Corp Stock Price To Earnings To Growth
| CVS Stock | EUR 46.53 1.67 3.46% |
CVS Health Corp fundamentals help investors to digest information that contributes to CVS Health's financial success or failures. It also enables traders to predict the movement of CVS Stock. The fundamental analysis module provides a way to measure CVS Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CVS Health stock.
CVS |
CVS Health Corp Company Price To Earnings To Growth Analysis
CVS Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current CVS Health Price To Earnings To Growth | 1.35 X |
Most of CVS Health's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS Health Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, CVS Health Corp has a Price To Earnings To Growth of 1.3451 times. This is 89.45% higher than that of the Healthcare sector and significantly higher than that of the Health Care Plans industry. The price to earnings to growth for all Germany stocks is 72.49% higher than that of the company.
CVS Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CVS Health's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CVS Health could also be used in its relative valuation, which is a method of valuing CVS Health by comparing valuation metrics of similar companies.CVS Health is number one stock in price to earnings to growth category among its peers.
CVS Fundamentals
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 173.98 B | |||
| Shares Outstanding | 1.28 B | |||
| Shares Owned By Insiders | 0.41 % | |||
| Shares Owned By Institutions | 82.27 % | |||
| Price To Earning | 14.93 X | |||
| Price To Book | 1.85 X | |||
| Price To Sales | 0.39 X | |||
| Revenue | 322.47 B | |||
| Gross Profit | 53.46 B | |||
| EBITDA | 12.16 B | |||
| Net Income | 4.15 B | |||
| Cash And Equivalents | 8.53 B | |||
| Cash Per Share | 6.55 X | |||
| Total Debt | 50.48 B | |||
| Debt To Equity | 149.20 % | |||
| Current Ratio | 0.95 X | |||
| Book Value Per Share | 54.63 X | |||
| Cash Flow From Operations | 16.18 B | |||
| Earnings Per Share | 2.96 X | |||
| Price To Earnings To Growth | 1.35 X | |||
| Number Of Employees | 219 K | |||
| Beta | 0.65 | |||
| Market Capitalization | 101.03 B | |||
| Total Asset | 228.28 B | |||
| Z Score | 2.2 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.11 % | |||
| Net Asset | 228.28 B | |||
| Last Dividend Paid | 2.2 |
About CVS Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CVS Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVS Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVS Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CVS Stock
When determining whether CVS Health Corp is a strong investment it is important to analyze CVS Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CVS Health's future performance. For an informed investment choice regarding CVS Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.